Internal Medicine · New York, NY
NPI
1962442699
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
110 Lafayette St Ste 601
New York, NY, 10013
Phone (516) 626-0177
Groups this clinician bills Medicare through
Medicare paid, 2024
$208K
15,941 services
Medicare patients, 2024
284
Average age 80
Drug cost, 2024
$8.7M
8,458 prescriptions
Company payments, 2025
$12K
From 57 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kin Lam was code 99214 (office e&m - established), 753 times for 215 patients. In total Kin Lam billed 15,941 services in 83 codes, and Medicare paid $208K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 753 | 215 | $106.43 | $80K |
| 36415 Venipuncture Blood Collection | Office | 277 | 145 | $8.65 | $2,396 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 251 | 14 | $0.09 | $22.54 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 241 | 99 | $53.70 | $13K |
| 96127 Behavioral Health Services | Office | 178 | 85 | $3.34 | $595 |
| 99213 Office E&M - Established | Office | 133 | 72 | $78.22 | $10K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 126 | 125 | $21.41 | $2,698 |
| 99497 Care Management/Coordination | Office | 123 | 119 | $63.56 | $7,818 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 86 | 86 | $145.97 | $13K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 79 | 79 | $21.49 | $1,698 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 65 | 61 | $11.85 | $770 |
| 99441 Telephone Services | Office | 58 | 45 | $43.67 | $2,533 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 52 | 20 | $0.52 | $27.16 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 42 | 30 | $42.53 | $1,786 |
| 96372 Injection Administration | Office | 42 | 18 | $12.80 | $538 |
By year: 2022 $267K for 14,739 services; 2023 $219K for 19,777 services; 2024 $208K for 15,941 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 277 | 145 | $8.65 | $2,396 |
| 85025 Blood Count | 39 | 20 | $7.61 | $297 |
Medicare prescription drug claims, 2024
In 2024, the drug Kin Lam prescribed most often to Medicare patients was Rosuvastatin Calcium, with 345 prescriptions and refills. In total Kin Lam wrote 8,458 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 345 | 951 | 157 | $3,843 |
| Amlodipine Besylate Generic | 310 | 851 | 149 | $2,001 |
| Losartan Potassium Generic | 285 | 781 | 126 | $2,315 |
| Atorvastatin Calcium Generic | 271 | 715 | 116 | $2,390 |
| Ammonium Lactate Generic | 164 | 185 | 59 | $4,848 |
| Celecoxib Generic | 137 | 137 | 92 | $2,089 |
| Tagrisso Osimertinib Mesylate | 134 | 134 | 20 | $2.3M |
| Azithromycin Generic | 128 | 129 | 102 | $319 |
| Clonazepam Generic | 127 | 127 | 68 | $868 |
| Tamsulosin Hcl Generic | 125 | 297 | 48 | $1,093 |
| Prednisone Generic | 120 | 126 | 35 | $560 |
| Levothyroxine Sodium Generic | 120 | 330 | 55 | $1,303 |
| Diclofenac Sodium Generic | 114 | 124 | 55 | $19K |
| Metoprolol Succinate Generic | 114 | 302 | 55 | $1,476 |
| Metformin Hcl Generic | 111 | 279 | 42 | $591 |
Brand drugs: 1,684 claims; generic drugs: 6,717 claims; opioid claims: 105.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kin Lam $12K ($12K in general payments such as food, travel and fees) from 57 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $1,391.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $1,391 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $1,117 |
| Pfizer Inc. PFE | 32 | $781 |
| Janssen Biotech, Inc. JNJ | 21 | $628 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $509 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $458 |
| Celgene Corporation BMY | 18 | $432 |
| BeOne Medicines USA, Inc. ONC | 14 | $431 |
| Daiichi Sankyo Inc. 4568.T | 9 | $427 |
| Eisai Inc. 4523.T | 14 | $385 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.